Literature DB >> 31762453

Analysis of Hematopoietic Stem Progenitor Cell Metabolism.

Giorgia Scapin1, Marie C Goulard1, Priyanka R Dharampuriya1, Jennifer L Cillis1, Dhvanit I Shah2.   

Abstract

Hematopoietic stem progenitor cells (HSPCs) have distinct metabolic plasticity, which allows them to transition from their quiescent state to a differentiation state to sustain demands of the blood formation. However, it has been difficult to analyze the metabolic status (mitochondrial respiration and glycolysis) of HSPCs due to their limited numbers and lack of optimized protocols for non-adherent, fragile HSPCs. Here, we provide a set of clear, step-by-step instructions to measure metabolic respiration (oxygen consumption rate; OCR) and glycolysis (extracellular acidification rate; ECAR) of murine bone marrow-LineagenegSca1+c-Kit+ (LSK) HSPCs. This protocol provides a higher amount of LSK HSPCs from murine bone marrow, improves the viability of HSPCs during incubation, facilitates extracellular flux analyses of non-adherent HSPCs, and provides optimized injection protocols (concentration and time) for drugs targeting oxidative phosphorylation and glycolytic pathways. This method enables the prediction of the metabolic status and the health of HSPCs during blood development and diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31762453      PMCID: PMC6897312          DOI: 10.3791/60234

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  28 in total

Review 1.  Inhibitors of the ATP synthethase system.

Authors:  P E Linnett; R B Beechey
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

Review 2.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

3.  Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells.

Authors:  Min Wu; Andy Neilson; Amy L Swift; Rebecca Moran; James Tamagnine; Diane Parslow; Suzanne Armistead; Kristie Lemire; Jim Orrell; Jay Teich; Steve Chomicz; David A Ferrick
Journal:  Am J Physiol Cell Physiol       Date:  2006-09-13       Impact factor: 4.249

Review 4.  Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation.

Authors:  E Fosslien
Journal:  Ann Clin Lab Sci       Date:  2001-01       Impact factor: 1.256

5.  Metabolism and the leukemic stem cell.

Authors:  Omar Abdel-Wahab; Ross L Levine
Journal:  J Exp Med       Date:  2010-04-05       Impact factor: 17.579

6.  An MTCH2 pathway repressing mitochondria metabolism regulates haematopoietic stem cell fate.

Authors:  Maria Maryanovich; Yehudit Zaltsman; Antonella Ruggiero; Andres Goldman; Liat Shachnai; Smadar Levin Zaidman; Ziv Porat; Karin Golan; Tsvee Lapidot; Atan Gross
Journal:  Nat Commun       Date:  2015-07-29       Impact factor: 14.919

7.  Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche.

Authors:  Younghun Jung; Junhui Song; Yusuke Shiozawa; Jingcheng Wang; Zhuo Wang; Benjamin Williams; Aaron Havens; Abraham Schneider; Chunxi Ge; Renny T Franceschi; Laurie K McCauley; Paul H Krebsbach; Russell S Taichman
Journal:  Stem Cells       Date:  2008-05-22       Impact factor: 6.277

Review 8.  Mitochondria in Cancer Energy Metabolism: Culprits or Bystanders?

Authors:  Aekyong Kim
Journal:  Toxicol Res       Date:  2015-12

9.  The mitochondrial respiratory chain is essential for haematopoietic stem cell function.

Authors:  Elena Ansó; Samuel E Weinberg; Lauren P Diebold; Benjamin J Thompson; Sébastien Malinge; Paul T Schumacker; Xin Liu; Yuannyu Zhang; Zhen Shao; Mya Steadman; Kelly M Marsh; Jian Xu; John D Crispino; Navdeep S Chandel
Journal:  Nat Cell Biol       Date:  2017-05-15       Impact factor: 28.824

Review 10.  Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last?

Authors:  Lise Van Wyngene; Jolien Vandewalle; Claude Libert
Journal:  EMBO Mol Med       Date:  2018-08       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.